ReviewJournal of medicinal chemistry2023

METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey.

Francesco Fiorentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.